Sensory hypersensitivity is commonly seen in FXS patients and the FXS mouse model - the Fmr1 knockout (KO). Recent data suggests that this abnormality stems from hyperexcitability in sensory circuits. We have established that cortical microcircuits are hyperexcitable in the Fmr1 KO mouse model, and that sensory responses are enhanced in Fmr1 KO mice and FXS patients. Thus, investigation of sensory sensitivities is clinically relevant, but perhaps more important is the promise of sensory system studies to advance understanding of the mechanisms and consequences of hyperexcitability in neocortical circuitry that could represent a primary pathophysiological factor impacting the development of a wide range of perceptual, cognitive, and language skills in FXS. Further, we have identified biochemical signaling mechanisms that may underlie hyperexcitability involving processes that we and others have uncovered that can be examined in detail in KO mouse models and tested in FXS patients to develop a foundation for novel therapeutic development. The striking consistency of findings across levels of investigation and species offers an unprecedented opportunity to investigate mechanisms of brain dysfunction in a mouse disease model and translate it directly to patients - a multidisciplinary mission that is ideal for a Center environment. Our Center is organized to pursue precisely this aim with a tightly integrated and highly novel scientific program of translational research. Project 1 (Huber/Gibson;UTSW;co-investigators) will determine the cellular, molecular and synaptic mechanisms of auditory neocortical dysfunction using in vitro brain slices in FXS mouse models. Project 2 (Razak/Etheii/Binder;UCR;co-investigators) will study auditory sensory processing deficits in vivo in FXS mouse models, test mechanisms, and examine developmental and structural correlates of these deficits. Project 3 (Sweeney/Byerly, UTSW, co-investigators) will investigate auditory cortical processing deficits using novel neurophysiological strategies in individuals with FXS. All Projects will examine candidate mechanisms of sensory hyperexcitability with an acute pharmacological probe strategy to test mechanisms of interest in parallel studies of mice and patients.
Sensory hypersensitivity and processing deficits significantly contribute to behavioral problems associated with Fragile X Syndrome (FXS);hyperexcitability and alterations sensory neocortex likely underlies these problems. We propose a multilevel, integrated approach to determine the pathophysiology of sensory neocortical dysfunction and directly link this to sensory processing deficits in FXS mouse models and patients. Candidate therapeutics to correct sensory processing deficits will be tested in mice and patients.
|Ethridge, L E; White, S P; Mosconi, M W et al. (2016) Reduced habituation of auditory evoked potentials indicate cortical hyper-excitability in Fragile X Syndrome. Transl Psychiatry 6:e787|
|Lovelace, Jonathan W; Wen, Teresa H; Reinhard, Sarah et al. (2016) Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome. Neurobiol Dis 89:126-35|
|Ouyang, Minhui; Cheng, Hua; Mishra, Virendra et al. (2016) Atypical age-dependent effects of autism on white matter microstructure in children of 2-7 years. Hum Brain Mapp 37:819-32|
|Takarae, Yukari; Sablich, Savanna R; White, Stormi P et al. (2016) Neurophysiological hyperresponsivity to sensory input in autism spectrum disorders. J Neurodev Disord 8:29|
|Mosconi, Matthew W; Mohanty, Suman; Greene, Rachel K et al. (2015) Feedforward and feedback motor control abnormalities implicate cerebellar dysfunctions in autism spectrum disorder. J Neurosci 35:2015-25|
|Guo, Weirui; Ceolin, Laura; Collins, Katie A et al. (2015) Elevated CaMKIIÎ± and Hyperphosphorylation of Homer Mediate Circuit Dysfunction in a Fragile X Syndrome Mouse Model. Cell Rep 13:2297-311|
|Miller, Haylie L; Ragozzino, Michael E; Cook, Edwin H et al. (2015) Cognitive set shifting deficits and their relationship to repetitive behaviors in autism spectrum disorder. J Autism Dev Disord 45:805-15|
|Najjar, Fedra; Owley, Thomas; Mosconi, Matthew W et al. (2015) Pharmacogenetic Study of Serotonin Transporter and 5HT2A Genotypes in Autism. J Child Adolesc Psychopharmacol 25:467-74|
|Mosconi, Matthew W; Wang, Zheng; Schmitt, Lauren M et al. (2015) The role of cerebellar circuitry alterations in the pathophysiology of autism spectrum disorders. Front Neurosci 9:296|
|Amodeo, Dionisio A; Jones, Joshua H; Sweeney, John A et al. (2014) Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J mice. Autism Res 7:555-67|